The commission shall conduct an analysis of each clinical initiative selected by the commission after having conducted the commission’s preliminary review under § 538.053(4). The analysis required under this section must include a review of:
(1) any public comments and submitted research relating to the initiative;
(2) the available clinical research and historical utilization information relating to the initiative;
(3) published medical literature relating to the initiative;
(4) any adoption of the initiative by medical societies or other clinical groups;
(5) whether the initiative has been implemented under:
(A) the Medicare program;
(B) another state medical assistance program; or
(C) a state-operated health care program, including the child health plan program;
(6) the results of reports, research, pilot programs, or clinical studies relating to the initiative conducted by:
(A) institutions of higher education, including related medical schools;
(B) governmental entities and agencies; and
(C) private and nonprofit think tanks and research groups;
(7) the impact that the initiative would have on Medicaid if the initiative were implemented in this state, including:
(A) an estimate of the number of recipients under Medicaid that would be impacted by implementation of the initiative; and
(B) a description of any potential cost savings to the state that would result from implementation of the initiative; and
(8) any statutory barriers to implementation of the initiative.

Text of section effective until April 01, 2025